Droia

Showing 1 posts of 1 posts found.

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018
Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …

Latest content